Expression of a functional c-kit receptor on a subset of natural killer cells
- PMID: 7688785
- PMCID: PMC2191187
- DOI: 10.1084/jem.178.3.1079
Expression of a functional c-kit receptor on a subset of natural killer cells
Abstract
Natural killer (NK) cells are large granular lymphocytes thought to be important in the host's early immune response to viral infection and malignant transformation. NK cells proliferate and display enhanced cytotoxic activity in response to the T cell growth factor, interleukin 2 (IL-2). Stem cell factor or steel factor (SF) is the ligand for the c-kit receptor, and when combined with other hematopoietic growth factors, SF synergistically promotes the proliferation and differentiation of bone marrow stem cells. In the present study we show the c-kit receptor to be uniquely expressed on a subset of resting human NK cells (CD56bright) which constitutively expresses both the high affinity IL-2 receptor (IL-2R) and the intermediate affinity IL-2R. Other lymphocyte populations, including CD56dim NK cells, did not appear to express the c-kit receptor. Within the CD56bright NK cell subset, SF alone had no obvious effect on proliferation or cytotoxic activity. SF was shown to significantly augment the proliferative effect of IL-2, and caused a marked shift in the dose-response curve at IL-2 concentrations that selectively saturate the high affinity IL-2R. The potentiating effect of SF on NK cell proliferation was dependent on IL-2 binding to the high affinity IL-2R, and was blocked by a monoclonal antibody directed against the c-kit receptor. SF did not enhance proliferation at higher IL-2 concentrations that saturate the intermediate affinity IL-2R, nor did SF enhance IL-2-induced cytotoxic activity. Together, these data indicate that SF and IL-2 act synergistically to directly augment the proliferative capacity of a unique human NK cell subset constitutively expressing the high affinity IL-2R and the c-kit receptor. The implications of these findings on NK cell development and the host's early immune response to pathogen invasion are discussed.
Similar articles
-
Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor.J Exp Med. 1994 Oct 1;180(4):1395-403. doi: 10.1084/jem.180.4.1395. J Exp Med. 1994. PMID: 7523571 Free PMC article.
-
CD56bright natural killer cell subsets: characterization of distinct functional responses to interleukin-2 and the c-kit ligand.Eur J Immunol. 1997 Feb;27(2):354-60. doi: 10.1002/eji.1830270203. Eur J Immunol. 1997. PMID: 9045904
-
Differential responses to interleukin 2 define functionally distinct subsets of human natural killer cells.Eur J Immunol. 1992 Jan;22(1):1-6. doi: 10.1002/eji.1830220102. Eur J Immunol. 1992. PMID: 1370410
-
Natural killer cells and nitric oxide.Int Immunopharmacol. 2001 Aug;1(8):1513-24. doi: 10.1016/s1567-5769(01)00095-9. Int Immunopharmacol. 2001. PMID: 11515816 Review.
-
Natural killer cells in multiple sclerosis: A review.Immunol Lett. 2020 Jun;222:1-11. doi: 10.1016/j.imlet.2020.02.012. Epub 2020 Feb 27. Immunol Lett. 2020. PMID: 32113900 Review.
Cited by
-
Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells.Blood. 2006 Dec 1;108(12):3824-33. doi: 10.1182/blood-2006-04-020198. Epub 2006 Aug 10. Blood. 2006. PMID: 16902150 Free PMC article.
-
Definition of a natural killer NKR-P1A+/CD56-/CD16- functionally immature human NK cell subset that differentiates in vitro in the presence of interleukin 12.J Exp Med. 1996 Nov 1;184(5):1845-56. doi: 10.1084/jem.184.5.1845. J Exp Med. 1996. PMID: 8920872 Free PMC article.
-
Human natural killer cells produce abundant macrophage inflammatory protein-1 alpha in response to monocyte-derived cytokines.J Clin Invest. 1996 Jun 15;97(12):2722-7. doi: 10.1172/JCI118726. J Clin Invest. 1996. PMID: 8675682 Free PMC article.
-
Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor.J Exp Med. 1994 Oct 1;180(4):1395-403. doi: 10.1084/jem.180.4.1395. J Exp Med. 1994. PMID: 7523571 Free PMC article.
-
c-Kit signaling potentiates CAR T cell efficacy in solid tumors by CD28- and IL-2-independent co-stimulation.Nat Cancer. 2023 Jul;4(7):1001-1015. doi: 10.1038/s43018-023-00573-4. Epub 2023 Jun 19. Nat Cancer. 2023. PMID: 37336986 Free PMC article.